Cisplatin (Privo Technologies)

顺铂透皮贴剂 (Privo Technologies)

Report date: 2025/12/10 20:01:13

Base Information

Drug NameCisplatin (Privo Technologies)

Drug Alias NameCisplatin Transmucosal System (Privo Technologies)Cisplatin transmucosal patch (Privo Technologies)Intratumoural cisplatin injectable (Privo Technologies)PRV211 patchPRV111 patch +[8]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA cross linking agentsDNA synthesis inhibitors

TargetsDNA

Therapy Area/IndicationsOral Squamous Cell Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesPrivo Technologies

China Registration ClassN/A

Develop Information

Active CompaniesPrivo Technologies

Inactive CompaniesN/A

Active IndicationsOral Squamous Cell Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeL01XA01